LSL Pharma Group Inc News

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announ

GlobeNewswireJun 28 17:37 ET

LSL Pharma to Raise $4.5 Million Via Private Placements

LSL Pharma Group (LSL.V), a Canadian pharmaceutical company, said on Wednesday that it plans to raise $4.5 Million via a combination of private placements. LSL intends to raise a maximum of $3 million

MT NewswiresJun 5 10:02 ET

LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units

08:37 AM EDT, 04/24/2024 (MT Newswires) -- LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units

MT NewswiresApr 24 08:37 ET

LSL Pharma Group Brief: Has Upsized Its Private Placement From $3.5 Million To $7.5 Million

09:19 AM EDT, 04/11/2024 (MT Newswires) -- LSL Pharma Group Brief: Has Upsized Its Private Placement From $3.5 Million To $7.5 Million

MT NewswiresApr 11 09:19 ET

Update: LSL Pharma Loses 5% As Raises $6.44 Million In First Closing Of Private Placements

LSL Pharma Group Inc. (LSL.V) said Tuesday that it secured $6.44 million in the first closing of its $8.0 million combined financings. The company issued 16,086,893 units priced at $0.40 apiece. Each

MT NewswiresMar 19 11:59 ET

LSL Pharma Raises $6.44 Million In First Closing Of Private Placements

LSL Pharma Group Inc. (LSL.V) said Tuesday that it secured $6.44 million in the first closing of its $8.0 million combined financings. The company issued 16,086,893 units priced at $0.40 apiece. Each

MT NewswiresMar 19 08:43 ET

LSL Pharma Group Announced An Extension Of Its Convertible Debentures Offering

Quebec's LSL Pharma Group Inc. (LSL.V) Monday announced that it is extending until February 7 its brokered private placement through the issuance of unsecured convertible debentures at a price of $10

MT NewswiresJan 8 13:44 ET

LSL Pharma Group Announces an Extension of Its Convertible Debentures Offering

BOUCHERVILLE, Québec, Jan. 08, 2024 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, announces that it ex

GlobeNewswireJan 8 07:00 ET

LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering

BOUCHERVILLE, Québec, Dec. 08, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, is pleased to announ

GlobeNewswireDec 8, 2023 12:41 ET

LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer

LSL Pharma Group (LSL.V) has appointed Luc Mainville as Senior Vice President and CFO effective December 4. Mainville brings extensive experience in the capital markets and life sciences industry. Ove

MT NewswiresDec 4, 2023 10:51 ET

LSL Pharma Group Inc. GAAP EPS of -C$0.01, Revenue of C$2.5M

Seeking AlphaNov 29, 2023 10:19 ET

LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering

BOUCHERVILLE, Québec, Nov. 01, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, is pleased to announ

GlobeNewswireNov 1, 2023 11:50 ET

Groupe LSL Pharma Announces New Orders With an Annual Revenue Potential in Excess of $2.6 Million

BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – ("the Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, announces today that

GlobeNewswireOct 25, 2023 07:00 ET

LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals

U.S. Food and Drug Administration grants temporary discretion to import critical Erythromycin ophthalmic ointment for treatment of newbornsBOUCHERVILLE, Québec, Oct. 18, 2023 (GLOBE NEWSWIRE) -- LS

GlobeNewswireOct 18, 2023 07:00 ET

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the "Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, is pleased to announ

GlobeNewswireOct 6, 2023 07:30 ET

LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000

Debenture proceeds will provide additional funds and flexibility for growthBOUCHERVILLE, Québec, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the "Company" or "LSL Pharma

GlobeNewswireSep 21, 2023 11:23 ET